Health Products

Ranitidine Injection USP (2020-08-27)

· Published by Health Canada · Official notice

Details

Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type I

Summary

Product

Ranitidine Injection USP

Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberBrand nameCompaniesDIN, NPN, DIN-HIMDosage formStrength
JX9941Ranitidine Injection USP
Recalling Firm
Sandoz Canada Inc
110 de Lauzon
Boucherville
J4B 1E6
Quebec
CANADA
Marketing Authorization Holder
Sandoz Canada Inc
110 de Lauzon
Boucherville
J4B 1E6
Quebec
CANADA
DIN 02256711SolutionRanitidine (Ranitidine Hydrochloride) 25 mg/mL

Reason

The affected lots may contain particles.

Depth of distribution

Healthcare establishments
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime